Literature DB >> 8021128

Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy.

J N Sarkaria1, P M Harari.   

Abstract

Squamous cell carcinoma (SCC) of the oral tongue in patients less than 40 years old is a rare but aggressive disease. Published reports suggest poor overall treatment results for young patients despite relatively early stage disease presentation. A 25-year review of the English language literature (1968 to 1993) identifies 14 reports with 3 or more patients younger than 40 years of age with SCC of the oral tongue. Of 152 cases identified, 57% of patients developed locoregional failure and 47% of patients died secondary to their cancer. At the University of Wisconsin Hospital and Clinics, 6 patients under the age of 40 years have received treatment between 1971 and 1991 for SCC of the oral tongue. Despite presentation with relatively early stage disease, 5 of 6 patients have developed locoregional failure and 4 patients have died from their cancer. These results for the younger population reflect a higher locoregional failure and mortality rate than representative reports from the older population. An aggressive therapeutic approach to the young patient with SCC of the oral tongue appears warranted in an attempt to improve locoregional control and ultimate survival.

Entities:  

Mesh:

Year:  1994        PMID: 8021128     DOI: 10.1002/hed.2880160202

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  44 in total

1.  Squamous cell carcinoma of the oral tongue in the pediatric age group: a matched-pair analysis of survival.

Authors:  Luc G T Morris; Snehal G Patel; Jatin P Shah; Ian Ganly
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-07

2.  Squamous Cell Carcinoma of the Oral Tongue in Young Patients: Outcomes and Implications for Treatment.

Authors:  Narayana Subramaniam; Deepak Balasubramanian; Tsu-Hui Hubert Low; Sivakumar Vidhyadharan; Anjali Menon; Samskruthi Murthy; Krishnakumar Thankappan; Jonathan R Clark; Kan Gao; Subramania Iyer
Journal:  Indian J Surg Oncol       Date:  2020-02-22

3.  Oral tongue carcinoma and its treatment in Finland.

Authors:  Antti A Mäkitie; Petri Koivunen; Harri Keski-Säntti; Jyrki Törnwall; Matti Pukkila; Jussi Laranne; Marjaana Luukkaa; Jyrki Vuola; Timo Joensuu; Mikael Kajanti; Reidar Grénman
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-09-21       Impact factor: 2.503

4.  Tongue carcinoma in an adult Down's syndrome patient: a case report.

Authors:  Fadi S Farhat; Fady Geara; Mohamed Natout; Jamal Serhal; Walid Daya
Journal:  World J Surg Oncol       Date:  2009-03-04       Impact factor: 2.754

5.  Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.

Authors:  Sarika Daripally; Sateesh Reddy Nallapalle; Saritha Katta; Vidudala V T S Prasad
Journal:  Tumour Biol       Date:  2015-05-06

6.  Early onset oral tongue squamous cell carcinoma: Associated factors and patient outcomes.

Authors:  Benjamin R Campbell; Courtney B Sanders; James L Netterville; Robert J Sinard; Sarah L Rohde; Alexander Langerman; Kyle Mannion; Young J Kim; Barbara A Murphy; James S Lewis; Jeremy L Warner; Derek K Smith; Krystle A Lang Kuhs
Journal:  Head Neck       Date:  2019-01-11       Impact factor: 3.147

7.  Outcomes of oral cavity squamous cell carcinoma in pediatric patients.

Authors:  Luc G T Morris; Ian Ganly
Journal:  Oral Oncol       Date:  2010-02-25       Impact factor: 5.337

Review 8.  Tongue carcinoma in young adults: a review of the literature.

Authors:  A Paderno; R Morello; C Piazza
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-06       Impact factor: 2.124

9.  Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age.

Authors:  Marilena Vered; Dan Dayan; Alex Dobriyan; Ran Yahalom; Bruria Shalmon; Iris Barshack; Lev Bedrin; Yoav P Talmi; Shlomo Taicher
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-07       Impact factor: 4.553

10.  Biomolecular markers in cancer of the tongue.

Authors:  Daris Ferrari; Carla Codecà; Jessica Fiore; Laura Moneghini; Silvano Bosari; Paolo Foa
Journal:  J Oncol       Date:  2009-08-19       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.